Lupin Digital Health marked the company’s foray into the fast-growing digital therapeutics space. Its Lyfe platform focuses on real-time monitoring of patients and offers interventions for cardiac ...

Global pharmaceutical giant Lupin Ltd. on Monday announced a significant milestone in its expansion strategy within the US market, securing tentative approval from the United States Food and Drug ...

Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older. Lupin has received tentative approval from the ...

Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg. This product would be ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

AMLODIPINE ATORVASTATIN MYLAN film-coated tablet 10 mg+10 mg Mylan Pharms Inc. AMLODIPINE ATORVASTATIN MYLAN film-coated tablet 10 mg+2.5 mg Mylan Pharms Inc ...

AMLODIPINE ATORVASTATIN MYLAN film-coated tablet 10 mg+10 mg Mylan Pharms Inc. AMLODIPINE ATORVASTATIN MYLAN film-coated tablet 10 mg+2.5 mg Mylan Pharms Inc ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application ...